Schizophrenia: a review
- PMID: 17619525
Schizophrenia: a review
Abstract
Schizophrenia is a debilitating mental illness that affects 1 percent of the population in all cultures. It affects equal numbers of men and women, but the onset is often later in women than in men. Schizophrenia is characterized by positive and negative symptoms. Positive symptoms include hallucinations, voices that converse with or about the patient, and delusions that are often paranoid. Negative symptoms include flattened affect, loss of a sense of pleasure, loss of will or drive, and social withdrawal. Both types of symptoms affect patients' families; therefore, it is important for physicians to provide guidance to all persons affected by the disease. Psychosocial and family interventions can improve outcomes. Medications can control symptoms, but virtually all antipsychotics have neurologic or physical side effects (e.g., weight gain, hypercholesterolemia, diabetes). There is a 10 percent lifetime risk of suicide in patients with schizophrenia.
Summary for patients in
-
Information from your family doctor. Helping a family member with schizophrenia.Am Fam Physician. 2007 Jun 15;75(12):1830. Am Fam Physician. 2007. PMID: 17619526 No abstract available.
Similar articles
-
Schizophrenia.J Fam Pract. 1983 Jul;17(1):99-102, 107-8, 111-4, passim. J Fam Pract. 1983. PMID: 6134780 Review.
-
[Pathophysiology of schizophrenia and its impact on pharmacotherapy].Fortschr Neurol Psychiatr. 2005 Nov;73 Suppl 1:S32-7. doi: 10.1055/s-2005-915546. Fortschr Neurol Psychiatr. 2005. PMID: 16270242 Review. German.
-
[Severe psychoses in the elderly--schizophrenia and delusional disorder].Duodecim. 2011;127(4):375-82. Duodecim. 2011. PMID: 21442857 Review. Finnish.
-
Use and safety of antipsychotic drugs during pregnancy.J Psychiatr Pract. 2009 May;15(3):183-92. doi: 10.1097/01.pra.0000351878.45260.94. J Psychiatr Pract. 2009. PMID: 19461391 Review.
-
Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction.Encephale. 2000 Oct;26 Spec No 1:12-4. Encephale. 2000. PMID: 11294057 English, French.
Cited by
-
Efficacy of behavioural activation in the treatment of negative symptoms in people with schizophrenia spectrum disorders: A systematic review.Int J Nurs Stud Adv. 2023 May 15;5:100132. doi: 10.1016/j.ijnsa.2023.100132. eCollection 2023 Dec. Int J Nurs Stud Adv. 2023. PMID: 38746587 Free PMC article. Review.
-
Australian trial of behavioural activation for people with schizophrenia experiencing negative symptoms: a feasibility randomised controlled trial protocol.BMJ Open. 2024 May 6;14(5):e080245. doi: 10.1136/bmjopen-2023-080245. BMJ Open. 2024. PMID: 38719282 Free PMC article.
-
Delineating mechanisms underlying parvalbumin neuron impairment in different neurological and neurodegenerative disorders: the emerging role of mitochondrial dysfunction.Biochem Soc Trans. 2024 Apr 24;52(2):553-565. doi: 10.1042/BST20230191. Biochem Soc Trans. 2024. PMID: 38563502 Free PMC article. Review.
-
Functional Connectivity of Language-Related Cerebellar Regions Is Reduced in Schizophrenia Patients.Biomedicines. 2024 Feb 21;12(3):480. doi: 10.3390/biomedicines12030480. Biomedicines. 2024. PMID: 38540094 Free PMC article.
-
Validation of an ICD-code-based case definition for psychotic illness across three health systems.medRxiv [Preprint]. 2024 Feb 29:2024.02.28.24303443. doi: 10.1101/2024.02.28.24303443. medRxiv. 2024. Update in: Schizophr Bull. 2024 May 10:sbae064. doi: 10.1093/schbul/sbae064. PMID: 38464074 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical